Neuroendocrine Aspects of Primary Endogenous Depression: I. Cortisol Secretory Dynamics in Patients and Matched Controls

Archives of General Psychiatry

Volumn 44, Issue 4, 1987, Pages 328-336

  Rubin, Robert T ^a   Poland, Russell E ^a   Lesser, Ira M ^a   Winston, Robert A ^b   Blodgett, A L Nelson ^c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b Cigna Health Plans ^*  (United States)

^c Santa Barbara County Public Health Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADULT; CENTRAL NERVOUS SYSTEM; CIRCADIAN RHYTHM; CLINICAL ARTICLE; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSIS; ENDOCRINE SYSTEM; HUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT;

ADULT; AGE FACTORS; AGED; BODY WEIGHT; CIRCADIAN RHYTHM; DEPRESSIVE DISORDER; DEXAMETHASONE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; PSYCHIATRIC STATUS RATING SCALES; SEX FACTORS;

EID: 0023091104     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1987.01800160032006     Document Type: Article

References (80)

1. Rubin RT, Gouin PR, Poland RE: Biogenic amine metabolism and neuroendocrine function in affective disorders, in de la Fuente R, Weisman MN (eds): Psychiatry: Proceedings of the V World Congress of Psychiatry. Princeton, NJ, Excerpta Medica, 1973, pp 1036-1039.
2. Rubin RT, Kendler KS: Psychoneuroendocrinology: Fundamental concepts and correlates in depression, in Usdin G (ed): Depression: Clinical, Biological, and Psychological Perspectives. New York, Brunner/Mazel Inc, 1977, pp 122-138.
3. Carroll BJ: Neuroendocrine function in affective disorders, in Lipton MA, DiMascio A, Killam KF (eds): Psychopharmacology: A Generation of Progress. New York, Raven Press, 1978, pp 487-497.
4. Rubin RT, Poland RE, Hays SE: Psychoneuroendocrine research in endogenous depression: A review, in Obiols J, Ballus C, Gonzales Monclus E, Pujol J (eds): Biological Psychiatry Today. Amsterdam, Elsevier Science Publishers, 1979, pp 684-688.
5. Checkley SA: Neuroendocrine tests of monoamine function in man: A review of basic theory and its application to the study of depressive illness. Psychol Med 1980;10:35-53.
6. Von Zerssen D, Doerr P: The role of the hypothalamo-pituitaryadrenocortical system in psychiatric disorders. Adv Biol Psychiatry 1980;5:85-106.
7. Rubin RT, Poland RE: The chronoendocrinology of endogenous depression, in Müller EE, MacLeod RM (eds): Neuroendocrine Perspectives, Vol 1. Amsterdam, Elsevier Science Publishers, 1982, pp 305-337.
8. Rubin RT, Poland RE: Neuroendocrine function in depression, in Angst J (ed): The Origins of Depression: Current Concepts and Approaches. New York, Springer-Verlag, 1983, pp 205-220.
9. Sachar EJ, Hellman L, Roffwarg HP, Halpern FS, Fukushima DK, Gallagher TF: Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psychiatry 1973;28:19-24.
10. Carroll BJ, Curtis GC, Mendels J: Neuroendocrine regulation in depression: I. Limbic system—adrenocortical dysfunction. Arch Gen Psychiatry 1976;33:1039-1044.
11. Pfohl B, Sherman B, Schlechte J, Stone R: Pituitary/adrenal axis rhythm disturbances in psychiatric depression. Arch Gen Psychiatry 1985;42:897-903.
12. Carroll BJ, Curtis GC, Mendels J: Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychol Med 1976;6:235-244.
13. Träskman L, Tybring G, Asberg M, Bertillson L, Lantto 0, Schalling D: Cortisol in the CSF of depressed and suicidal patients. Arch Gen Psychiatry 1980;37:761-767.
14. Carroll BJ, Curtis GC, Davies BM, Mendels J, Sugerman AA: Urinary free cortisol excretion in depression. Psychol Med 1976;6:43-50.
15. Carroll BJ, Curtis GC, Mendels J: Neuroendocrine regulation in depression: II. Discrimination of depressed from non-depressed patients. Arch Gen Psychiatry 1976;33:1051-1058.
16. Carroll BJ: Control of plasma cortisol levels in depression: Studies with the dexamethasone suppression test, in Davies B, Carroll BJ, Mowbray RM (eds): Depressive Illness: Some Research Studies. Springfield, Ill, Charles C Thomas Publishers, 1972, pp 87-148.
17. Stokes PE, Pick GR, Stoll PM, Nunn WD: Pituitary-adrenal function in depressed patients: Resistance to dexamethasone suppression. J Psychiatr Res 1975;12:271-281.
18. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, Kronfol Z, Lohr N, Steiner M, de Vigne JP, Young E: A specific laboratory test for the diagnosis of melancholia: Standardization, validation, and clinical utility. Arch Gen Psychiatry 1981;38:15-22.
19. Carroll BJ: The dexamethasone suppression test for melancholia. Br J Psychiatry 1982;140:292-304.
20. Holsboer F: The dexamethasone suppression test in depressed patients: Clinical and biochemical aspects. J Steroid Biochem 1983;19:251-257.
21. Green HS, Kane JM: Review: The dexamethasone suppression test in depression. Clin Neuropharmacol 1983;6:7-24.
22. Shapiro MF, Lehman AF: The diagnosis of depression in different clinical settings: An analysis of the literature on the dexamethasone suppression test. J Nerv Ment Dis 1983;171:714-720.
23. Berger M, Klein HE: Der Dexamethason-Suppressions-Test: Ein biologischer Marker der endogenen Depression? Eur Arch Psychiatry Neurol Sci 1984;234:137-146.
24. Rubin RT, Poland RE: The dexamethasone suppression test in depression: Advantages and limitations, in Burrows GD, Norman TR, Maguire KP (eds): Biological Psychiatry: Recent Studies. London, John Libbey, 1984, pp 76-83.
25. Carroll BJ: Dexamethasone suppression test: A review of contemporary confusion. J Clin Psychiatry 1985;46:13-24.
26. Coryell W: The use of laboratory tests in psychiatric diagnosis: The DST as an example. Psychiatr Dev 1984;3:139-159.
27. Arana GW, Baldessarini RJ, Ornsteen M: The dexamethasone suppression test for diagnosis and prognosis in psychiatry: Commentary and review. Arch Gen Psychiatry 1985;42:1193-1204.
28. Amsterdam JC, Winokur A, Abelman E, Lucki I, Rickels K: Cosyntropin (ACTHα1-24) stimulation test in depressed patients and healthy subjects. Am J Psychiatry 1983;140:907-909.
29. Holsboer F, Müller OA, Doerr HG, Sippell WG, Stalla GK, Gerken A, Steiger B, Boll E, Benkert O: ACTH and multisteroid responses to corticotropin-releasing factor in depressive illness: Relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression. Psychoneuroendocrinology 1984;9:147-160.
30. Gold PW, Chrousos G, Kellner C, Post R, Roy A, Augerinos P, Schulte H, Oldfield E, Loriaux DL: Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am J Psychiatry 1984;141:619-627.
31. Holsboer F, von Bardesleben U, Gerken A, Stalla GK, Müller OA: Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor in depression. N Engl J Med 1984;311:1127.
32. Rubin RT, Poland RE, Blodgett ALN, Winston RA, Forster B, Carroll BJ: Cortisol dynamics and dexamethasone pharmacokinetics in primary endogenous depression: Preliminary findings, in Brambilla F, Racagni G, deWied D (eds): Progress in Psychoneuroendocrinology. Amsterdam, Elsevier Science Publishers, 1980, pp 223-234.
33. Endicott J, Spitzer RL: A diagnostic interview: The schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978;35:837-844.
34. Spitzer RL, Endicott J, Robins E: Research diagnostic criteria: Rationale and reliability. Arch Gen Psychiatry 1978;35:773-782.
35. Endicott J, Spitzer RL: Use of the Research Diagnostic Criteria and the schedule for affective disorders and schizophrenia to study affective disorders. Am J Psychiatry 1979;136:52-56.
36. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296.
37. Hedlund JL, Vieweg BW: The Hamilton rating scale for depression: A comprehensive review. J Operat Psychiatry 1979;10:149-165.
38. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
39. Beck AT: Depression: Clinical, Experimental and Theoretical Aspects. New York, Harper & Row Publishers Inc, 1967.
40. Vankirk K, Sassin JF: Technique for serial blood sampling during sleep recording. Am J EEG Technol 1969;9:143-146.
41. Rubin RT, Zir LM, Smith RA, Fagan T, Adler R: Experience with the Vankirk-Sassin technique for serial blood sampling during sleep. Am J EEG Technol 1971;11:17-18.
42. Foster LB, Dunn RT: Single antibody technique for radioimmunoassay of cortisol in unextracted serum or plasma. Clin Chem 1974;20:365-368.
43. Poland RE, Rubin RT: Saliva cortisol levels following dexamethasone administration in endogenously depressed patients. Life Sci 1982;30:177-181.
44. Murphy BEP: Clinical evaluation of urinary cortisol determination by competitive protein-binding radioassay. J Clin Endocrinol Metab 1968;28:343-348.
45. Chang PC, Rubin RT, Yu M: Optimal statistical design of radioimmunoassay and competitive protein-binding assays. Endocrinology 1975;96:973-981.
46. Murphy BEP: Some studies of the protein binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein binding radioassay. J Clin Endocrinol Metab 1967;27:973-990.
47. Marascuilo LA, McSweeney M: Nonparametric and Distribution Free Methods for the Social Sciences. Monterey, Calif, Brooks/Cole, 1977.
48. Jacobs KW: A table for the determination of experimentwise error rate (alpha) from independent comparisons. Educ Psychol Meas 1976;36:899-903.
49. Dommisse CS, Hayes PE, Kwentus JA: Effect of estrogens on the dexamethasone suppression test in nondepressed women. J Clin Psychopharmacol 1985;5:315-319.
50. Jarrett DB, Coble P, Kupfer DJ: Reduced cortisol latency in depressive illness. Arch Gen Psychiatry 1983;40:506-511.
51. Brandenberger G, Follenius M, Hietter B: Feedback from mealrelated peaks determines diurnal changes in cortisol response to exercise. J Clin Endocrinol Metab 1982;54:592-596.
52. Quigley ME, Yen SSC: A mid-day surge in cortisol levels. J Clin Endocrinol Metab 1979;49:945-947.
53. Follenius M, Brandenberger G, Hietter B: Diurnal cortisol peaks and their relationships to meals. J Clin Endocrinol Metab 1982;55:757-761.
54. Goldman J, Wajchenberg BL, Liberman B, Nery M, Achando S, Germek OA: Contrast analysis for the evaluation of the circadian rhythms of plasma cortisol, androstenedione, and testosterone in normal men and the possible influence of meals. J Clin Endocrinol Metab 1985;60:164-167.
55. Asnis GM, Sachar EJ, Halbreich U, Nathan RS, Ostrow L, Halpern FS: Cortisol secretion and dexamethasone response in depression. Am J Psychiatry 1981;138:1218-1221.
56. Halbreich U, Asnis GM, Shindledecker R, Zumoff B, Nathan RS: Cortisol secretion in endogenous depression: I. Basal plasma levels. Arch Gen Psychiatry 1985;42:904-908.
57. Halbreich U, Asnis GM, Shindledecker R, Zumoff B, Nathan RS: Cortisol secretion in endogenous depression: II. Time-related functions. Arch Gen Psychiatry 1985;42:909-914.
58. Halbreich U, Zumoff B, Kream J, Fukushima DK: The mean 1300-1600 h plasma cortisol concentration as a diagnostic test for hypercortisolism. J Clin Endocrinol Metab 1982;54:1262-1264.
59. Asnis GM, Halbreich U, Sachar EJ, Nathan RS, Davies M, Novacenko H, Ostrow L, Endicott J, Puig-Antich J: Relationship of dexamethasone (2 mg) and plasma cortisol hypersecretion in depressive illness: Clinical and neuroendocrine parameters. Psychopharmacol Bull 1982;18:122-126.
60. Holsboer F, Gerken A, Steiger A, Fass V: Mean 14.00-17.00 h plasma cortisol concentration and its relationship to the 1 mg-dexamethasone suppression response in depressives and controls. Acta Psychiatr Scand 1984;69:383-390.
61. Frank E, Jarrett DB, Kupfer DJ, Grochocinski V: Biological and clinical predictors of response in recurrent depression: A preliminary report. Psychiatry Res 1984;13:315-324.
62. Asnis GM, Sachar EJ, Halbreich U, Nathan RS, Novacenko N, Ostrow LC: Cortisol secretion in relation to age in major depression. Psychosom Med 1981;43:235-242.
63. Feinberg M, Carroll BJ: Biological ‘markers’ for endogenous depression: Effect of age, severity of illness, weight loss, and polarity. Arch Gen Psychiatry 1984;41:1080-1085.
64. Nelson JC, Charney DS, Vingiano AW: False-positive diagnosis with primary-affective-disorder criteria. Lancet 1978;2:1252-1253.
65. Feinberg M, Carroll BJ, Steiner M, Commorato A: Misdiagnoses of endogenous depression with research diagnostic criteria. Lancet 1979;1:267.
66. Nelson JC, Charney DS: Primary affective disorder criteria and the endogenous-reactive distinction. Arch Gen Psychiatry 1980;37:787-793.
67. Gibbons JL: Cortisol secretion rate in depressive illness. Arch Gen Psychiatry 1964;10:572-575.
68. Sherman B, Pfohl B, Winokur G: Circadian analysis of plasma cortisol levels before and after dexamethasone administration in depressed patients. Arch Gen Psychiatry 1984;41:271-275.
69. Amsterdam JD, Winokur A, Caroff SN, Conn J: The dexamethasone suppression test in outpatients with primary affective disorder and healthy control subjects. Am J Psychiatry 1982;139:287-291.
70. Vandewalle J, Charles G, Mardens Y, Mendlewicz J: Dexamethasone resistance and cortisol secretion in depressive illness. Biol Psychiatry 1983;18:385-389.
71. Berger M, Doerr P, Lund R, Bronisch T, von Zerssen D: Neuroendocrinological and neurophysiological studies in major depressive disorders: Are there biological markers for the endogenous subtype? Biol Psychiatry 1982;17:1217-1242.
72. Brown WA, Keitner G, Qualls B, Haier R: The dexamethasone suppression test and pituitary-adrenocortical function. Arch Gen Psychiatry 1985;42:121-123.
73. Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E: Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups: A multicenter study. Arch Gen Psychiatry 1984;41:257-267.
74. Zimmerman M, Coryell W: Limited utility of the 1-mg dexamethasone suppression test as a measure of hypercortisolism. Arch Gen Psychiatry 1985;42:200-201.
75. Davis KL, Hollister LE, Mathe AA, Davis BM, Rothpearl AB, Faull KF, Hsieh JYK, Barchas JD, Berger PA: Neuroendocrine and neurochemical measurements in depression. Am J Psychiatry 1981;138:1555-1562.
76. Charles G, Vandewalle J, Meunier JC, Wilmotte J, Noel G, Fossoul C, Mardens Y, Mendlewicz J: Plasma and urinary cortisol levels after dexamethasone in affective disorders. J Affective Disord 1981;3:397-406.
77. Sachar EJ: Neuroendocrine abnormalities in depressive illness, in Sachar EJ (ed): Topics in Psychoendocrinology. New York, Grune & Stratton, 1975, pp 135-153.
78. Claustrat B, Chazot G, Brun J, Jorden D, Sassolas G: A Chronobiological study of melatonin and cortisol secretion in depressed subjects: Plasma melatonin, a biochemical marker in major depression. Biol Psychiatry 1984;19:1215-1228.
79. Glass AR, Zavadil AP, Halberg F, Cornelissen G, Schaff M: Circadian rhythm of cortisol in Cushing's disease. J Clin Endocrinol Metab 1984;59:161-165.
80. Wehr TA, Gillin JC, Goodwin FK: Sleep and circadian rhythms in depression, in Chase M, Weitzman ED (eds): Sleep Disorders: Basic and Clinical Research. Jamaica, NY, Spectrum Publishers Inc, 1983, pp 195-225.